Key result
SPECT-first and CTCA-first strategies are linked to ~46% lower radiation exposure than ICA-first testing.
Why the study?
Cumulative radiation exposure associated with contemporary diagnostic pathways for suspected chronic coronary syndromes and the impact of imaging strategies, downstream testing, geographic variability, and guideline adoption on radiation burden were not well characterized.
Does a non-invasive first-line imaging strategy reduce cumulative radiation exposure compared to an ICA-first strategy in patients with suspected chronic coronary syndromes?
Observational (n=2,058)
Yes
Does a non-invasive first-line imaging strategy reduce cumulative radiation exposure compared to an ICA-first strategy in patients with suspected chronic coronary syndromes?
Absolute Event Rate: 6.68% vs 12.6%
p-value: p=<0.001
Non-invasive, guideline-directed diagnostic pathways utilizing SPECT or CTCA lead to significantly lower cumulative radiation exposure compared to an upfront invasive coronary angiography strategy in suspected chronic coronary syndromes.
AIMS: To evaluate cumulative radiation exposure associated with contemporary diagnostic pathways in patients with suspected chronic coronary syndromes (CCS), and to assess the impact of first-line imaging strategies, downstream testing, geographic variability, and adoption of guideline-recommendations on radiation burden. METHODS AND RESULTS: This sub-analysis of the prospective, multicentre EURECA Imaging registry included 2058 patients (out of 2306 with available radiation data) undergoing at least one ionizing imaging test across 24 countries. Effective dose (ED) was calculated for each modality and cumulatively across diagnostic pathways. Median cumulative ED differed significantly according to initial testing strategy (p < 0.001). Single-photon emission computed tomography (SPECT)-first and computed tomography coronary angiography (CTCA)-first approaches were associated with a significantly lower radiation exposure (median ED 6.68 mSv, IQR 5.12-9.05 and 6.86 mSv, IQR 5.32-10.64, respectively), than an invasive coronary angiography (ICA)-first strategy (12.60 mSv, IQR 3.86-35.68). Marked inter-regional variability was observed across all modalities, with the highest doses generally reported in Eastern and Southern European countries. Guideline-adopting diagnostic pathways were associated with significantly lower cumulative ED in several regions. At multivariable analysis, hypertension, obesity, former smoking, and family history of coronary artery disease were independently associated with higher radiation exposure, while female sex, non-anginal symptoms, and guideline adoption predicted lower ED (all p < 0.01). CONCLUSIONS: Cumulative radiation exposure in CCS varies substantially according to diagnostic strategy and practice patterns. Non-invasive, guideline-adopting pathways are associated with lower radiation burden, whereas ICA-first approaches lead to higher exposure. Optimizing test selection and promoting guidelines adoption may improve radiation safety in cardiovascular imaging.
No takes yet. Share an insight, caveat, or question.
Gimelli et al. (2026) conducted an observational in Suspected chronic coronary syndromes (CCS) (n=2,058). SPECT-first or CTCA-first diagnostic strategies vs. Invasive coronary angiography (ICA)-first strategy was evaluated on Cumulative radiation exposure (Effective dose in mSv) (p=<0.001). SPECT-first and CTCA-first diagnostic strategies were associated with significantly lower median cumulative radiation exposure (6.68 mSv and 6.86 mSv) than an ICA-first strategy (12.60 mSv; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: